Abnormal expressions of c-MET and EGFR were reported in various human cancers where they support the proliferation and survival of cancer cells (Nicholson et al., 1990; Normanno et al., 2006; Zhang et al., 2018; Chakraborty et al., 2019; Fujiwara et al., 2020; Lee et al., 2020). The gene discussed is MET; the disease is cancer.